關於這家中國公司的產品，Chat GPT這樣說的：

can you give me details about the company agebox and its main product iKids-Growth, and why FDA gives warning on this drug may contains performance enhancement chemical?

下麵是它的回答：

ChatGPT said:

Here’s a detailed summary of what is known so far about AGEBOX (or “Agebox”) and its product iKids-Growth, and why the FDA issued a warning about it.

What is AGEBOX and iKids-Growth

AGEBOX / Agebox

AGEBOX (or Agebox) is described as a U.S.-based biotechnology / nutraceutical company focused on formulations that support children’s growth, cognition, etc.
Morningstar
+2
Nutraceutical Business Review
+2

According to a press release, they present “iKids-Growth” as a “safe and natural support for children’s height development.”
Nutraceutical Business Review
+2
Morningstar
+2

The company claims that iKids-Growth “syncs with the body’s natural growth signalling system,” meaning they assert it complements natural physiological regulation rather than acting directly as a strong agent.
Nutraceutical Business Review

In their promotional materials, they emphasize that the formulation is “hormone-free.”
Morningstar

iKids-Growth

iKids-Growth is marketed as a supplement (or “nutraceutical”) intended to help children reach their growth / height potential by enhancing the body’s ability to translate nutrition, sleep, and activity into growth.
Nutraceutical Business Review
+2
Morningstar
+2

It appears there are sub-formulas or variants (e.g. “Day Formula,” “Night Formula”) under the iKids-Growth brand. The FDA warning specifically references the Day formula.
U.S. Food and Drug Administration
+1

There is at least one registered clinical trial (in China) purporting to evaluate the “dietary supplement ‘iKids-Growth’ in improving height growth” in a specific patient group (SRS patients aged 1 to 3). (SRS = presumably “Silver-Russell syndrome” or similar growth-disorder context)
Chictr

The company frames iKids-Growth as an “evidence-based dietary supplement,” though whether that evidence is peer-reviewed and robust is uncertain.
Morningstar
+1

In summary: AGEBOX presents itself as a biotech / nutraceutical company and positions iKids-Growth as a (non-hormonal) growth support supplement for children.

FDA Warning and Hidden Ingredient Concern

In September 2025, the FDA issued a Medication Health Fraud Notification concerning Agebox iKids Growth Day Formula.
U.S. Food and Drug Administration
+1
The key points:

Undeclared Ibutamoren Detected

FDA’s laboratory analysis found that the product contains ibutamoren, which was not listed on the product label.
U.S. Food and Drug Administration

Ibutamoren (also known as MK-677) is a growth hormone secretagogue (a compound that stimulates the secretion of growth hormone). It is not an approved ingredient for over-the-counter supplements for children in the U.S.
U.S. Food and Drug Administration
+2
U.S. Food and Drug Administration
+2

Because it is a pharmacologically active compound with effects on hormone regulation, its presence constitutes a “hidden drug” in the supplement. The FDA considers that serious.
U.S. Food and Drug Administration

Risks / Why FDA is Concerned

The presence of ibutamoren means the product is misbranded: what’s inside differs from what’s claimed on the label.

It may pose safety risks, especially in children, because pharmacologically active hormones or hormone-modulating agents can have unintended consequences (e.g. on endocrine regulation, growth plates, other organs).

The product is being marketed as a “supplement” but in effect acts (or at least contains) a drug-like agent.

Because ibutamoren is not approved in this context and is not disclosed, consumers (or clinicians) cannot evaluate risks appropriately.

Hence, the FDA’s warning: "Agebox iKids Growth Day Formula may be harmful due to hidden ingredient."
U.S. Food and Drug Administration

Additionally, in the FDA’s Health Fraud Product Database, iKids Growth (Day and Night formulas) are listed under “undisclosed ibutamoren.”
U.S. Food and Drug Administration

Countries outside the U.S. have also flagged it. For example, the Hong Kong Drug Office published a notice that the product was found to contain a non-listed Western medicine (i.e. ibutamoren) in the Day formula.
Drug Office

Why ibutamoren is Considered a “performance enhancement / hormonal” chemical

Ibutamoren / MK-677 is a compound known to stimulate the release of growth hormone (GH) and increase levels of insulin-like growth factor 1 (IGF-1). Because GH is part of the body’s anabolic / growth / repair system, it can have “performance enhancement” or growth-promoting effects.

It is not considered a benign vitamin or nutritional additive; it acts on hormonal pathways. Thus, its presence is tantamount to inserting a drug (or drug-like agent) into what is marketed as a supplement.

In sports and doping contexts, GH / GH secretagogues are of concern because of their potential to increase muscle growth, metabolism, or recovery beyond normal physiological levels.

Because ibutamoren is pharmacologically active and may shift the endocrine balance, its use carries risks (e.g. abnormal growth, joint issues, glucose metabolism changes, etc.). For that reason, regulators often treat such substances with caution or restrict their use.

So in the FDA’s view, the undisclosed presence of ibutamoren essentially means the product is adulterated with a hormone-modulating agent — hence a “performance enhancement chemical” not declared, making it unsafe and non-compliant.

Limitations / Unknowns & Caveats

I did not find reliable public sources confirming the full corporate structure, history, financials, or regulatory filings of AGEBOX beyond promotional press and supplementary notices.

The actual dosage of ibutamoren in iKids-Growth Day Formula (as detected) is not publicly detailed in the FDA notice (or at least is not in the summary) — so the magnitude of risk depends on dose, frequency, and exposure, which is not fully disclosed to the public in the notice.

The claims by AGEBOX about being “hormone-free” are undercut by the FDA finding; but one would need full batch testing, independent studies, and regulatory scrutiny to fully verify product consistency.

The clinical trial listing in China suggests that iKids-Growth is being tested in certain clinical settings, but trial registration does not guarantee results, regulatory oversight, or safety.
Chictr

If you like, I can pull up the exact FDA lab test report showing the concentration of ibutamoren in that product, or check whether there have been any legal actions or recalls. Do you want me to dig into that?